These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 26692658

  • 1. Questions of fairness and anti-doping in US cycling: The contrasting experiences of professionals and amateurs.
    Henning AD, Dimeo P.
    Drugs (Abingdon Engl); 2015 Sep 03; 22(5):400-409. PubMed ID: 26692658
    [Abstract] [Full Text] [Related]

  • 2. Condemning and condoning: Elite amateur cyclists' perspectives on drug use and professional cycling.
    Outram SM, Stewart B.
    Int J Drug Policy; 2015 Jul 03; 26(7):682-7. PubMed ID: 25666447
    [Abstract] [Full Text] [Related]

  • 3. The new front in the war on doping: Amateur athletes.
    Henning AD, Dimeo P.
    Int J Drug Policy; 2018 Jan 03; 51():128-136. PubMed ID: 28619395
    [Abstract] [Full Text] [Related]

  • 4. Challenges to promoting health for amateur athletes through anti-doping policy.
    Henning A.
    Drugs (Abingdon Engl); 2017 Jan 03; 24(3):306-313. PubMed ID: 28736489
    [Abstract] [Full Text] [Related]

  • 5. Clean Olympians? Doping and anti-doping: the views of talented young British athletes.
    Bloodworth A, McNamee M.
    Int J Drug Policy; 2010 Jul 03; 21(4):276-82. PubMed ID: 20056401
    [Abstract] [Full Text] [Related]

  • 6. [Not Available].
    Bieri A, Kamber M, Sterchi M, Mullis PE.
    Ther Umsch; 2014 Apr 03; 71(4):245-52. PubMed ID: 24670606
    [Abstract] [Full Text] [Related]

  • 7. Health and doping in elite-level cycling.
    Lentillon-Kaestner V, Hagger MS, Hardcastle S.
    Scand J Med Sci Sports; 2012 Oct 03; 22(5):596-606. PubMed ID: 21392123
    [Abstract] [Full Text] [Related]

  • 8. Current anti-doping policy: a critical appraisal.
    Kayser B, Mauron A, Miah A.
    BMC Med Ethics; 2007 Mar 29; 8():2. PubMed ID: 17394662
    [Abstract] [Full Text] [Related]

  • 9. Risk and enabling environments in sport: Systematic doping as harm reduction.
    Henning A, McLean K, Andreasson J, Dimeo P.
    Int J Drug Policy; 2021 May 29; 91():102897. PubMed ID: 32768155
    [Abstract] [Full Text] [Related]

  • 10. The World Anti-Doping Code in sport: Update for 2015.
    Hughes D.
    Aust Prescr; 2015 Oct 29; 38(5):167-70. PubMed ID: 26648655
    [Abstract] [Full Text] [Related]

  • 11. Doping control from a global and national perspective.
    Fraser AD.
    Ther Drug Monit; 2004 Apr 29; 26(2):171-4. PubMed ID: 15228160
    [Abstract] [Full Text] [Related]

  • 12. The Prevalence and Outlook of Doping in Electronic Sports (Esports): An Original Study and Review of the Overlooked Medical Challenges.
    Słyk S, Zarzycki M, Grudzień K, Majewski G, Jasny M, Domitrz I.
    Cureus; 2023 Nov 29; 15(11):e48490. PubMed ID: 38074032
    [Abstract] [Full Text] [Related]

  • 13. The unethicality of doping in sports.
    Palmi I, Berretta P, Tini A, Ricci G, Marinelli S.
    Clin Ter; 2019 Nov 29; 170(2):e100-e101. PubMed ID: 30993304
    [Abstract] [Full Text] [Related]

  • 14. The complexities of anti-doping violations: a case study of sanctioned cases in all performance levels of USA cycling.
    Henning AD, Dimeo P.
    Perform Enhanc Health; 2014 Nov 29; 3(3-4):159-166. PubMed ID: 26688790
    [Abstract] [Full Text] [Related]

  • 15. Perception of the Current Anti-doping Regime - A Quantitative Study Among German Top-Level Cyclists and Track and Field Athletes.
    Westmattelmann D, Dreiskämper D, Strauß B, Schewe G, Plass J.
    Front Psychol; 2018 Nov 29; 9():1890. PubMed ID: 30386274
    [Abstract] [Full Text] [Related]

  • 16. Self-reported attitudes of elite athletes towards doping: differences between type of sport.
    Alaranta A, Alaranta H, Holmila J, Palmu P, Pietilä K, Helenius I.
    Int J Sports Med; 2006 Oct 29; 27(10):842-6. PubMed ID: 16586338
    [Abstract] [Full Text] [Related]

  • 17. National doping prevention guidelines: Intent, efficacy and lessons learned - A 4-year evaluation.
    Wippert PM, Fließer M.
    Subst Abuse Treat Prev Policy; 2016 Oct 10; 11(1):35. PubMed ID: 27724975
    [Abstract] [Full Text] [Related]

  • 18. Doping use among young elite cyclists: a qualitative psychosociological approach.
    Lentillon-Kaestner V, Carstairs C.
    Scand J Med Sci Sports; 2010 Apr 10; 20(2):336-45. PubMed ID: 19486486
    [Abstract] [Full Text] [Related]

  • 19. Banned substances and their incidence: A retrospective view of the national laboratory of prevention and doping control of Mexico.
    Mercado Soberanes K, Camacho Frías E, Rodríguez Balandrán L, Rodríguez Fermán ME, Mendoza Méndez N, Velasco-Bejarano B.
    Adicciones; 2019 Jul 01; 31(3):201-211. PubMed ID: 30059594
    [Abstract] [Full Text] [Related]

  • 20. The development of doping use in high-level cycling: from team-organized doping to advances in the fight against doping.
    Lentillon-Kaestner V.
    Scand J Med Sci Sports; 2013 Mar 01; 23(2):189-97. PubMed ID: 22092601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.